125 related articles for article (PubMed ID: 21310202)
21. Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter.
Chu XY; Sánchez-Castaño GP; Higaki K; Oh DM; Hsu CP; Amidon GL
J Pharmacol Exp Ther; 2001 Nov; 299(2):575-82. PubMed ID: 11602669
[TBL] [Abstract][Full Text] [Related]
22. Rosiglitazone and metformin have opposite effects on intestinal absorption of oligopeptides via the proton-dependent PepT1 transporter.
Hindlet P; Barraud C; Boschat L; Farinotti R; Bado A; Buyse M
Mol Pharmacol; 2012 Mar; 81(3):319-27. PubMed ID: 22108913
[TBL] [Abstract][Full Text] [Related]
23. OAT1 and OAT3: targets of drug-drug interaction between entecavir and JBP485.
Xu Q; Wang C; Meng Q; Liu Q; Sun H; Peng J; Ma X; Kaku T; Liu K
Eur J Pharm Sci; 2013 Mar; 48(4-5):650-7. PubMed ID: 23313623
[TBL] [Abstract][Full Text] [Related]
24. The bioactive dipeptide anserine is transported by human proton-coupled peptide transporters.
Geissler S; Zwarg M; Knütter I; Markwardt F; Brandsch M
FEBS J; 2010 Feb; 277(3):790-5. PubMed ID: 20067523
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic interaction between JBP485 and cephalexin in rats.
Zhang J; Wang C; Liu Q; Meng Q; Cang J; Sun H; Gao Y; Kaku T; Liu K
Drug Metab Dispos; 2010 Jun; 38(6):930-8. PubMed ID: 20219852
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor-alpha and interferon-gamma increase PepT1 expression and activity in the human colon carcinoma cell line Caco-2/bbe and in mouse intestine.
Vavricka SR; Musch MW; Fujiya M; Kles K; Chang L; Eloranta JJ; Kullak-Ublick GA; Drabik K; Merlin D; Chang EB
Pflugers Arch; 2006 Apr; 452(1):71-80. PubMed ID: 16328452
[TBL] [Abstract][Full Text] [Related]
27. Conjugation of dipeptide to fluorescent dyes enhances its affinity for a dipeptide transporter (PEPT1) in human intestinal Caco-2 cells.
Abe H; Satoh M; Miyauchi S; Shuto S; Matsuda A; Kamo N
Bioconjug Chem; 1999; 10(1):24-31. PubMed ID: 9893960
[TBL] [Abstract][Full Text] [Related]
28. Mechanistic insights into PEPT1-mediated transport of a novel antiepileptic, NP-647.
Khomane KS; Nandekar PP; Wahlang B; Bagul P; Shaikh N; Pawar YB; Meena CL; Sangamwar AT; Jain R; Tikoo K; Bansal AK
Mol Pharm; 2012 Sep; 9(9):2458-68. PubMed ID: 22779445
[TBL] [Abstract][Full Text] [Related]
29. Acyclovir prodrug for the intestinal di/tri-peptide transporter PEPT1: comparison of in vivo bioavailability in rats and transport in Caco-2 cells.
Thomsen AE; Christensen MS; Bagger MA; Steffansen B
Eur J Pharm Sci; 2004 Dec; 23(4-5):319-25. PubMed ID: 15567284
[TBL] [Abstract][Full Text] [Related]
30. Oseltamivir (tamiflu) is a substrate of peptide transporter 1.
Ogihara T; Kano T; Wagatsuma T; Wada S; Yabuuchi H; Enomoto S; Morimoto K; Shirasaka Y; Kobayashi S; Tamai I
Drug Metab Dispos; 2009 Aug; 37(8):1676-81. PubMed ID: 19439487
[TBL] [Abstract][Full Text] [Related]
31. Transport of the phosphonodipeptide alafosfalin by the H+/peptide cotransporters PEPT1 and PEPT2 in intestinal and renal epithelial cells.
Neumann J; Bruch M; Gebauer S; Brandsch M
Eur J Biochem; 2004 May; 271(10):2012-7. PubMed ID: 15128310
[TBL] [Abstract][Full Text] [Related]
32. Peptide derivation of poorly absorbable drug allows intestinal absorption via peptide transporter.
Kikuchi A; Tomoyasu T; Tanaka M; Kanamitsu K; Sasabe H; Maeda T; Odomi M; Tamai I
J Pharm Sci; 2009 May; 98(5):1775-87. PubMed ID: 18781650
[TBL] [Abstract][Full Text] [Related]
33. Increased protein level of PEPT1 intestinal H+-peptide cotransporter upregulates absorption of glycylsarcosine and ceftibuten in 5/6 nephrectomized rats.
Shimizu Y; Masuda S; Nishihara K; Ji L; Okuda M; Inui K
Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G664-70. PubMed ID: 15528259
[TBL] [Abstract][Full Text] [Related]
34. Prediction of glycylsarcosine transport in Caco-2 cell lines expressing PEPT1 at different levels.
Irie M; Terada T; Tsuda M; Katsura T; Inui K
Pflugers Arch; 2006 Apr; 452(1):64-70. PubMed ID: 16283203
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the effect of ethanol's toxic metabolite acetaldehyde on the gastrointestinal oligopeptide transporter, PEPT1: in vitro and in vivo studies.
Fisher SJ; Lee IJ; Swaan PW; Eddington ND
Alcohol Clin Exp Res; 2008 Jan; 32(1):162-70. PubMed ID: 18028524
[TBL] [Abstract][Full Text] [Related]
36. Diurnal rhythm of H+-peptide cotransporter in rat small intestine.
Pan X; Terada T; Irie M; Saito H; Inui K
Am J Physiol Gastrointest Liver Physiol; 2002 Jul; 283(1):G57-64. PubMed ID: 12065292
[TBL] [Abstract][Full Text] [Related]
37. High-affinity interaction of sartans with H+/peptide transporters.
Knütter I; Kottra G; Fischer W; Daniel H; Brandsch M
Drug Metab Dispos; 2009 Jan; 37(1):143-9. PubMed ID: 18824524
[TBL] [Abstract][Full Text] [Related]
38. Decreased activity and expression of intestinal oligopeptide transporter PEPT1 in rats with hyperthyroidism in vivo.
Ashida K; Katsura T; Saito H; Inui K
Pharm Res; 2004 Jun; 21(6):969-75. PubMed ID: 15212161
[TBL] [Abstract][Full Text] [Related]
39. Visualized absorption of anti-atherosclerotic dipeptide, Trp-His, in Sprague-Dawley rats by LC-MS and MALDI-MS imaging analyses.
Tanaka M; Hong SM; Akiyama S; Hu QQ; Matsui T
Mol Nutr Food Res; 2015 Aug; 59(8):1541-9. PubMed ID: 25808120
[TBL] [Abstract][Full Text] [Related]
40. Protection of carbon monoxide intraperitoneal administration from rat intestine injury induced by lipopolysaccharide.
Liu SH; Ma K; Xu B; Xu XR
Chin Med J (Engl); 2010 Apr; 123(8):1039-46. PubMed ID: 20497711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
